Novartis, CMS Continue To Talk On Visudyne Macular Degeneration Coverage
Novartis and the Centers for Medicare & Medicaid Services will be meeting right up until the deadline for expanded coverage for Novartis/QLT's Visudyne
Novartis and the Centers for Medicare & Medicaid Services will be meeting right up until the deadline for expanded coverage for Novartis/QLT's Visudyne